Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.68% |
| 2 | Technology | 12.88% |
| 3 | Consumer Staples | 9.84% |
| 4 | Communication Services | 9.02% |
| 5 | Financials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
RBB Bancorp
RBB
$463M
| $1.99M | ﹤0.01% |
145,000
-30,700
| -17% | -$550K |
|
|
CCRN
2052
DELISTED
Cross Country Healthcare
CCRN
| $1.98M | ﹤0.01% |
294,382
-164,548
| -36% | -$1.56M |
|
|
HMNF
2053
DELISTED
HMN Financial Inc
HMNF
| $1.98M | ﹤0.01% |
110,100
+2,400
| +2% | +$47.4K |
|
2054
Altimmune
ALT
$570M
| $1.98M | ﹤0.01% |
617,007
+443,656
| +256% | +$1.02M |
|
2055
Cass Information Systems
CASS
$747M
| $1.98M | ﹤0.01% |
56,349
-623
| -1% | -$30.1K |
|
|
RJET
2056
Republic Airways Holdings
RJET
$951M
| $1.97M | ﹤0.01% |
39,945
-15,999
| -29% | -$1.64M |
|
|
KREF
2057
KKR Real Estate Finance Trust
KREF
$493M
| $1.97M | ﹤0.01% |
131,100
+45,472
| +53% | +$860K |
|
2058
Corvus Pharmaceuticals
CRVS
$1.23B
| $1.96M | ﹤0.01% |
930,700
+24,500
| +3% | +$99.5K |
|
2059
Four Corners Property Trust
FCPT
$2.77B
| $1.96M | ﹤0.01% |
+104,800
| New | +$2.83M |
|
2060
UTStarcom
UTSI
$23.5M
| $1.96M | ﹤0.01% |
284,707
-1,050
| -0.4% | -$10.8K |
|
|
SFE
2061
DELISTED
Safeguard Scientifics, Inc.
SFE
| $1.96M | ﹤0.01% |
352,917
+135,300
| +62% | +$1.21M |
|
2062
Crown Crafts
CRWS
$30.2M
| $1.96M | ﹤0.01% |
409,408
-18,893
| -4% | -$112K |
|
|
VWTR
2063
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $1.95M | ﹤0.01% |
250,900
+156,000
| +164% | +$1.5M |
|
|
NBIS
2064
Nebius Group N.V.
NBIS
$74.3B
| $1.95M | ﹤0.01% |
57,200
-322,381
| -85% | -$13.3M |
|
|
HNP
2065
DELISTED
Huaneng Power Intl, Inc.
HNP
| $1.95M | ﹤0.01% |
135,200
+38,700
| +40% | +$673K |
|
2066
Celldex Therapeutics
CLDX
$3.29B
| $1.94M | ﹤0.01% |
1,170,187
+54,819
| +5% | +$124K |
|
2067
iShares Core S&P 500 ETF
IVV
$908B
| $1.94M | ﹤0.01% |
+7,500
| New | +$2.3M |
|
|
ORTX
2068
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.94M | ﹤0.01% |
25,720
+23,350
| +985% | +$2.69M |
|
2069
AMN Healthcare
AMN
$1.33B
| $1.93M | ﹤0.01% |
+33,400
| New | +$2.29M |
|
2070
Beazer Homes USA
BZH
$872M
| $1.93M | ﹤0.01% |
299,860
+16,460
| +6% | +$204K |
|
|
VIOT
2071
Viomi Technology
VIOT
$47.2M
| $1.93M | ﹤0.01% |
442,832
+214,442
| +94% | +$1.45M |
|
2072
Morgan Stanley
MS
$342B
| $1.92M | ﹤0.01% |
+56,500
| New | +$2.66M |
|
|
DOC
2073
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.92M | ﹤0.01% |
+137,800
| New | +$2.53M |
|
|
CTIC
2074
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.92M | ﹤0.01% |
2,086,124
+118,210
| +6% | +$135K |
|
|
ADXS
2075
DELISTED
Advaxis Inc
ADXS
| $1.91M | ﹤0.01% |
3,610,419
-169,664
| -4% | -$148K |
|
Similar funds
Jim Simons's Q1 2020 Portfolio in Review
As of Q1 2020, Jim Simons held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jim Simons's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Jim Simons added most to Baidu in Q1 2020, an estimated $462M increase.
- Jim Simons's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Jim Simons fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Jim Simons's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Jim Simons opened 573 new positions and closed 645 in Q1 2020.
- Jim Simons's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.